Contact Us: 01282 426380
KM Financial Solutions | UPDATE 2-Medtronic settles states’ probe into Infuse marketing for $12 mln
5514
post-template-default,single,single-post,postid-5514,single-format-standard,qode-quick-links-1.0,ajax_fade,page_not_loaded,,qode_grid_1300,footer_responsive_adv,hide_top_bar_on_mobile_header,qode-child-theme-ver-1.0.0,qode-theme-ver-11.2,qode-theme-bridge,wpb-js-composer js-comp-ver-5.2.1,vc_responsive
 

UPDATE 2-Medtronic settles states’ probe into Infuse marketing for $12 mln

12 Dec UPDATE 2-Medtronic settles states’ probe into Infuse marketing for $12 mln

Posted at 19:29h in News by
0 Likes
BOSTON, Dec 13 (Reuters) – Medtronic Plc has agreed
to pay $12 million to resolve claims that the company engaged in
a deceptive marketing strategy to promote its Infuse bone graft
product used in spinal surgery, the Massachusetts attorney
general said on Wednesday.

No Comments

Sorry, the comment form is closed at this time.